CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma

被引：0
|
作者：
Young Chang
Yun Bin Lee
Eun Ju Cho
Jeong-Hoon Lee
Su Jong Yu
Yoon Jun Kim
Jung-Hwan Yoon
机构：
[1] Department of Internal Medicine and Liver Research Institute,Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine
[2] Seoul National University College of Medicine,undefined
[3] Soonchunhyang University College of Medicine,undefined
来源：
BMC Cancer | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma
    Jiang, Xiufeng
    Feng, Kang
    Zhang, Ye
    Li, Zengyao
    Zhou, Fan
    Dou, Huiqiang
    Wang, Tong
    ONCOTARGET, 2015, 6 (14) : 12340 - 12356
  • [22] Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway
    Hsu, Fu-Shun
    Wu, June-Tai
    Lin, Jing-Yi
    Yang, Shao-Ping
    Kuo, Kuan-Lin
    Lin, Wei-Chou
    Shi, Chung-Sheng
    Chow, Po-Ming
    Liao, Shih-Ming
    Pan, Chun-I
    Hong, Jo-Yu
    Chang, Hong-Chiang
    Huang, Kuo-How
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05):
  • [23] Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma
    Gundula Streubel
    Sabine Schrepfer
    Hannah Kallus
    Ulrike Parnitzke
    Tanja Wulff
    Frank Hermann
    Matthias Borgmann
    Svetlana Hamm
    Scientific Reports, 11
  • [24] THE NOVEL PAN-DEACETYLASE INHIBITOR PANOBINOSTAT INDUCES ALTERNATIVE PATHWAYS OF APOPTOSIS IN HEPATOCELLULAR CARCINOMA MODELS
    Di Fazio, P.
    Schneider-Stock, R.
    Wissniowski, T.
    Gahr, S.
    Neureiter, D.
    Ocker, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S190 - S191
  • [25] The novel pan-deacetylase inhibitor panobinostat induces alternative pathways of apoptosis in hepatocellular carcinoma models
    Di Fazio, Pietro
    Schneider-Stock, Regine
    Wissniowski, Till
    Gahr, Susanne
    Neureiter, Daniel
    Ocker, Matthias
    CANCER RESEARCH, 2009, 69
  • [26] Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma
    Streubel, Gundula
    Schrepfer, Sabine
    Kallus, Hannah
    Parnitzke, Ulrike
    Wulff, Tanja
    Hermann, Frank
    Borgmann, Matthias
    Hamm, Svetlana
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
    Choi, Seung Ah
    Kwak, Pil Ae
    Park, Chul-Kee
    Wang, Kyu-Chang
    Phi, Ji Hoon
    Lee, Ji Yeoun
    Lee, Chang Sik
    Lee, Ju-Hee
    Kim, Seung-Ki
    ONCOTARGET, 2017, 8 (06) : 9123 - 9133
  • [28] Safety and Efficacy of Abexinostat, a Pan-Histone Deacetylase (HDAC) Inhibitor, in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Results of an Ongoing Phase 2 Study
    Ribrag, Vincent
    Kim, Won Seog
    Bouabdallah, Reda
    Lim, Soon Thye
    Coiffier, Bertrand
    Felloussi, Zakia
    Kloos, Ioana
    Luan, Ying
    Graef, Thorsten
    Morschhauser, Franck
    BLOOD, 2015, 126 (23)
  • [29] Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells
    Zhao, Weijia
    Bai, Binglong
    Hong, Zhong
    Zhang, Xuming
    Zhou, Bin
    ACS OMEGA, 2020, 5 (38): : 24838 - 24847
  • [30] Comparison of the Antifibrotic Efficacy of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-Drug Pirfenidone in Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis
    Korfei, M.
    Stelmaszek, D.
    Skwarna, S.
    Chillappagari, S.
    Bach, A. C.
    MacKenzie, B.
    Ruppert, C.
    Saito, S.
    Mahavadi, P.
    Klepetko, W.
    Fink, L.
    Seeger, W.
    Lasky, J. A.
    Pullamsetti, S. S.
    Kraemer, O.
    Guenther, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345